Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

AZ pushes immuno-oncology duo into phase III

MEDI4736 and tremelimumab achieved disease control in 48% of NSCLC patients

- PMLiVE

90TEN Healthcare rebrands its communications service

Consultancy has worked with psychologists on the new approach, Life.Changing.

- PMLiVE

Paolo Paoletti named as executive chairman of Kesios

Paoletti was formerly president of GSK Oncology

Teva Pharma logo

Teva updates MS campaign with new online resource

You Don’t Know Jack About MS website features documentaries and blogs

- PMLiVE

Understanding the patient ecosystem

Creating a truly patient-centric approach must become pharma’s mantra

- PMLiVE

For richer or poorer

Holding on to employees that stand out from the crowd

- PMLiVE

The Directory unveils new agency shortlist tool

Follows the successful re-launch of the brand in April

How do you solve a problem like non-adherence? Part 2

Following her previous piece on patient medical non-adherence, Head of Customer Experience Elisa del Galdo takes a look at the different patient personas that emerge during the diagnosis and treatment...

Blue Latitude Health

- PMLiVE

FDA approves Pfizer’s new cancer pill

Drug was previously approved as an organ rejection treatment

- PMLiVE

Merck files all-oral hepatitis C therapy in US

Seeking approval for grazoprevir and elbasvir, which already has FDA breakthrough status

- PMLiVE

Boehringer launches iPhone app for patients on Gilotrif

App offers treatment guide for those taking its cancer drug

- PMLiVE

Pfizer ‘bids €1.5bn’ for CAR-T specialist Cellectis

French immuno-oncology biotech reported to be next on pharma giant's hit list

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links